Stay updated on RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Sign up to get notified when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.

Latest updates to the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now includes a dedicated Locations section with Pennsylvania and Utah; older Pennsylvania Locations and Utah Locations sections have been replaced by this consolidated Locations block.SummaryDifference0.3%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check52 days agoChange DetectedThe notice about government funding lapse and operating status has been removed from the page.SummaryDifference0.4%

- Check66 days agoChange DetectedNo additions or deletions to core page content were detected; the study details and contact information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check95 days agoChange Detected- Updated version from v3.1.0 to v3.2.0. - Added a government-operating-status notice about funding lapse and the NIH Clinical Center openness, directing users to cc.nih.gov and opm.gov for status updates.SummaryDifference3%

- Check102 days agoChange DetectedUpdated contact details and versioning: added multiple new emails/phone numbers for various contacts and bumped the revision from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma
Enter your email address, and we'll notify you when there's something new on the RadVax Clinical Trial: Immunotherapy and Radiation in Melanoma page.